Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tylenol Allergy/Sinus more effective than Claritin for "overall symptoms" in trial -- McNeil.

This article was originally published in The Tan Sheet

Executive Summary

TYLENOL ALLERGY/SINUS CLINICAL TRIAL COMPARISON TO CLARITIN indicates the OTC product is more effective in treating "overall symptoms" of allergies than Schering-Plough's prescription market leader loratadine, McNeil Consumer Products said Aug. 20. The Tylenol marketer cited preliminary results of two multi-center randomized studies involving 560 subjects with moderate to severe allergies.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088809

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel